Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
Search results for:
Al hydroxide/Mg hydroxide/simethicone
Al hydroxide/Mg hydroxide/simethicone
Drug Name
Form
Strength
Non-Formulary
Restricted
Renal Dosing
REMS
Therapeutic Interchange
Notes
Mi-Acid
SUSPENSION, ORAL
200 mg-200 mg-20 mg/5 mL
Alumina/Magnesia/Simethicone
SUSPENSION, ORAL
400 mg-400 mg-40 mg/5 mL
VIEW MORE
Antacids and Absorbents
CLASS
560400
Additional Information:
Drug Name
Common Side Effects
Al hydroxide/Mg hydroxide/simethicone
constipation
nausea, vomiting
accumulation with kidney disease (avoid prolonged use)
Last updated:
Aug. 22, 2022
UpToDate
Recent Citations via Medline (PubMed)
FDA Daily Med Package Inserts
FDA Approved Drug Products
Drugs.com/Pill Identifier
Rhazdrugs:
Al hydroxide/Mg hydroxide/simethicone